B2TIR4 AF NFT

Ketol-acid reductoisomerase (NADP(+))

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeicpelppbe3uduljst32eh5mru6hmhehomtv6tmsno53ocdrcz2xo4/metadata.json
IPFS of structure file: 
bafybeie4gsbea7eybyjxfbdqcqnbnkm4vf7tayqycskvjmlyirdmmfryeq/AF-B2TIR4-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x71112d4fF7ebb3b617963c05f052289e073082FD
First NFT owner address (bech32): 
genesis1wygj6nlhawemv9uk8szlq53gncrnpqha56an79
Current NFT ID #188419 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
188419
Accession (UniProt):
B2TIR4
Name::
Ketol-acid reductoisomerase (NADP(+))
Experimental Method:
Predicted structure
Sequence source:
Clostridium botulinum (strain Eklund 17B / Type B)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2TIR4 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2TIR4|ILVC_CLOBB Ketol-acid reductoisomerase (NADP(+)) OS=Clostridium botulinum (strain Eklund 17B / Type B) OX=935198 GN=ilvC PE=3 SV=1 MTKMYYEEDTDLNLLKGKTIAVIGYGSQGHAHALNAKESGGNVIIGLYEGSKSWAKAEAQGFEVFSTAEAAKKADIIMILINDELQAAMYKKDIAPNLEAGNMLMFAHGFNIHFDQITAPNDVDVTMIAPKGPGHTVRSEYQLGKGVPCLVAVHQDATGRALETALAYANAIGGARAGVLETTFRTETETDLFGEQAVLCGGVCALMQAGFETLVEAGYDERNAYFECIHEMKLIVDLIYQSGFAGMRYSISNTAEYGDYITGSKIITEETKKTMKKVLKDIQDGTFAKDFLLDMSEAGGQAHFKAMRKLAAEHQSEAVGSEIRKLYCWNNEDKLINN